Characterization of serotonergic mechanisms involved in the behavioural inhibition induced by 5-hydroxytryptophan in a modified light-dark test in mice

Behavioural Pharmacology

Volumn 9, Issue 2, 1998, Pages 103-112

  Artaiz, I ^a   Zazpe, A ^a   Del Rio J ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

5 HT receptors; 5 hydroxytryptophan; Animal model of anxiety; Anxiolytics; Light dark box; Mouse; Serotonin

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 4 AMINO 5 CHLORO 2 METHOXYBENZOIC ACID 3 PIPERIDINOPROPYL ESTER; 5 HYDROXYTRYPTOPHAN; ANXIOLYTIC AGENT; BUSPIRONE; FENCLONINE; FLUOXETINE; GRANISETRON; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ONDANSETRON; RITANSERIN; SEROTONIN; SEROTONIN 1A AGONIST; SEROTONIN 1A ANTAGONIST; SEROTONIN 2 ANTAGONIST; SEROTONIN 3 ANTAGONIST; SEROTONIN 4 ANTAGONIST; SEROTONIN RECEPTOR; SEROTONIN UPTAKE INHIBITOR; TROPISETRON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG RECEPTOR BINDING; INTRAPERITONEAL DRUG ADMINISTRATION; LABORATORY TEST; LIGHT DARK CYCLE; MALE; MOUSE; NONHUMAN; SEROTONINERGIC SYSTEM; SUBCUTANEOUS DRUG ADMINISTRATION;

5-HYDROXYTRYPTOPHAN; ANIMALS; FENCLONINE; FLUOXETINE; MALE; MICE; PSYCHOMOTOR PERFORMANCE; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN ANTAGONISTS; SEROTONIN UPTAKE INHIBITORS;

EID: 0031902007     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Andrews N, File SE (1993). Increased 5-HT release mediates the anxiogenic response during benzodiazepine withdrawal: a review of supporting neurochemical and behavioural evidence. Psychopharmacology 112:21-25.
2. 1A receptors in the median raphe nucleus and dorsal hippocampus may mediate anxiolytic and anxiogenic behaviours respectively. Eur J Pharmacol 264:259-264.
3. 3 receptor antagonist with anxiolytic-like properties in animal models. Psychopharmacology 117:137-148.
4. 1A antagonists. Trends Neurosci 19: 378-383.
5. A receptor antagonist with anxiolytic-like activity in animal models. Br J Pharmacol 121:759-767.
6. Barnes NM, Cheng CHK, Costall B, Ge J, Kelly ME, Naylor RJ (1992). Profiles of interaction of R(+)/S(-) zacopride, anxiolytic agents in a mouse model. Eur J Pharmacol 218:91-100.
7. Barrett JE, Vanover KE (1993). 5-HT receptors as targets for the development of novel anxiolytic drugs: models, mechanisms and future directions. Psychopharmacology 112:1-12.
8. Bill DJ, Coleman J, Hallett I, Middlefell VC, Rhodes KF, Fletcher A (1995). The enantiomers of zacopride: an intraspecies comparison of their potencies in functional and anxiolytic models. Br J Pharmacol 115:775-780.
9. 1A receptors causes amnesia and anxiolytic-like but not antidepressant-like effects in the rat. Eur J Pharmacol 234:215-221.
10. Cheng CHK, Costall B, Kelly ME, Naylor RJ (1994). Actions of 5-hydroxytryptophan to inhibit and disinhibit mouse behaviour in the light/dark test. Ear J Pharmacol 255:39-49.
11. 4 receptor. Int Clin Psychopharmacol 8 (suppl. 2):11-18.
12. Costall B, Naylor RJ (1995). Behavioural interactions between 5-hydroxytryptophan, neuroleptic agents and 5-HT receptor antagonists in modifying rodent responding to aversive situations. Br J Pharmacol 116:2989-2999.
13. Costall B, Jones BJ, Kelly ME, Naylor RJ, Tomkins DM (1989). Exploration of mice in a black and white test box: validation as a model of anxiety. Pharmacol Biochem Behav 32: 777-785.
14. Crawley JN, Goodwin FK (1980). Preliminary report of a simple animal behaviour model for the anxiolytic effects of benzodiazepines. Pharmacol Biochem Behav 13:167-170.
15. Curran HV, Shine P, Lader M (1984). Effects of repeated doses of fluvoxamine, mianserin and placebo on memory and measures of sedation. Psychopharmacology 89:360-363.
16. De Angelis L, Furlan Ch (1995). The effects of ascorbic acid and oxiracetam on scopolamine-induced amnesia in a habituation test in aged mice. Neurobiol Learn and Mem 64:119-124.
17. De Pablo JM, Parra A, Segovia S. Guillamon A (1989). Learned immobility explains the behavior of rats in the forced swimming test. Physiol Behav 46:229-237.
18. 1A receptor agonists: recent developments and controversial issues. Psychopharmacology 121:1-26.
19. 1A receptor antagonists: utility as research tools and therapeutic agents. Trends Pharmacol Sci 14:441-448.
20. Flood JF, Cherkin A (1987). Fluoxetine enhances memory processing in mice. Psychopharmacology 93:36-43.
21. Fontana DJ, Daniels SE, Henderson C, Eglen RM, Wong EHF (1995). Ondansetron improves cognitive performance in the Morris water maze spatial navigation task. Psychopharmacology 120:409-417.
22. Gartside SE, Cowen PJ, Sharp T (1992). Effect of 5-hydroxy-L-tryptophan on the release of 5-HT in rat hypothalamus in vivo as measured by microdialysis. Neuropharmacology 31:9-14.
23. Geller I, Seifter J (1962). The effects of mono-urethanes, di-urethanes and barbiturates on a punishment discrimination. J Pharmacol Exp Ther 136:284-288.
24. 3 receptor antagonists: a critical update on therapeutic potential. Trends Pharmacol Sci 14:265-270.
25. Handley SL, McBlane JW (1993). 5-HT drugs in animal models of anxiety. Psychopharmacology 112:13-20.
26. Handley SL, McBlane JW, Critchley MAE, Njung'e K (1993). Multiple serotonin mechanisms in animal models of anxiety: environmental, emotional and cognitive factors. Behav Brain Res 58:203-210.
27. Hodges H, Green S, Glenn B (1987). Evidence that the amygdala is involved in benzodiazepine and serotonergic effects on punished responding but not discrimination. Psychopharmacology 92:491-504.
28. Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharene EJ et al. (1994). International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 46:157-203.
29. Iversen SD (1984). 5-HT and anxiety. Neuropharmacology 23:1553-1560.
30. 1c receptor antagonists. Eur J Pharmacol 164:445-454.
31. Kilfoil T, Michel A, Montgomery D, Whiting RL (1989). Effects of anxiolytic and anxiogenic drugs on exploratory activity in a simple model of anxiety in mice. Neuropharmacology 28:901-905.
32. Kshama D, Hrishikeshavan HJ, Shanbhogue R, Munonyedi US (1990). Modulation of baseline behaviour in rats by putative serotonergic agents in three ethoexperimental paradigms. Behav Neural Biol 54:234-253.
33. Lucas JJ, Hen R (1995). New players in the 5-HT receptor field: genes and knockouts. Trends Pharmacol Sci 16:246-252.
34. Matsuo M, Kataoka Y, Mataki S, Kato Y, Oi K (1996). Conflict situation increases serotonin release in rat dorsal hippocampus: in vivo study with microdialysis and Vogel test. Neurosci Lett 215:197-200.
35. 1A agonists. Mol Pharmacol 37:231-237.
36. 1A ligands, 8-OH-DPAT and MDL 73005EF, in mice. NeuroReport 1:267-270.
37. Naranjo JR, Arnedo A, Molinero MT, Del Río J (1989). Involvement of spinal monoaminergic pathways in antinociception produced by substance P and neurotensin in rodents. Neuropharmacology 28:291-298.
38. Pérez-Otaño I, Herrero MT, Oset C, De Ceballos ML, Luquin MR, Obeso JA, Del Río J (1991). Extensive loss of brain dopamine and serotonin induced by chronic administration of MPTP in the marmoset. Brain Research 567:127-132.
39. Porsolt RD, LcPichon M, Jalfre M (1997). Depression: a new animal model sensitive to antidepressant treatment. Nature 266:730-732.
40. 1A receptor. Soc Neurosci Abstr 23:289.
41. 3 receptor antagonists in development as anxiolytics. Expert Opinion on Investigational Drugs 4:333-342.
42. Rowan MJ, Cullen WK, Moulton B (1990). Buspirone impairment of performance of passive avoidance and spatial learning tasks in the rat. Psychopharmacology 100:393-398.
43. Sánchez C (1995). Serotonergic mechanisms involved in the exploratory behaviour of mice in a fully automated two-compartment black and white test box. Pharmacology and Toxicology 77:71-78.
44. Young R, Johnson DN (1991). A fully automated light/dark apparatus useful for comparing anxiolytic agents. Pharmacol Biochem Behav 40:739-743.
45. Zifa E, Fillion G (1992). 5-hydroxytryptamine receptors. Pharmacol Rev 44:401-458.